An experimental drug is found to preferentially dilate autoregulatory coronary arterioles without affecting large conducting vessels. It is likely to:: (A) Evoke coronary steal phenomenon, (B) Mitigate classical angina but not variant angina, (C) Produce tachycardia as an adverse effect, (D) Useful in CHF
Answer is A. None